Advice
Following a full submission.
Accepted for restricted use within NHS Scotland.
Olmesartan has been shown to be at least as effective as other angiotensin II receptor antagonists (AIIAs) for the treatment of hypertension. It may be considered for use, along with other A11As, as an alternative in patients unable to tolerate an ACE inhibitor.
Download detailed advice18KB (PDF)
Medicine details
- Medicine name:
- olmesartan medoxomil (Olmetec)
- SMC ID:
- 78/03
- Indication:
- Hypertension
- Pharmaceutical company
- Sankyo Pharma UK Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 10 November 2003